These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 6065036)
21. [Clinical use of topical glutathione for cataract]. Kandori F; Kurimoto S; Fukunaga K; Suyama T; Honda I Nippon Ganka Gakkai Zasshi; 1967 Jun; 71(6):689-97. PubMed ID: 5624656 [No Abstract] [Full Text] [Related]
22. A trial of 'lacribase', a new ophthalmic vehicle. Maclure GM Br J Clin Pract; 1967 Aug; 21(8):397-400. PubMed ID: 6076263 [No Abstract] [Full Text] [Related]
23. Incidence of postoperative posterior capsular opacification following treatment with diclofenac 0.1% and ketorolac 0.5% ophthalmic solutions: 3-year randomized, double-masked, prospective clinical investigation. Flach AJ; Dolan BJ Trans Am Ophthalmol Soc; 2000; 98():101-5; discussion 105-7. PubMed ID: 11190013 [TBL] [Abstract][Full Text] [Related]
24. [Use of the preparation quinax in the trial treatment of senile and secondary cataract]. Zygulska-Mach H; Pioruńska M; Paziewski E Wiad Lek; 1982 Nov; 35(19-20):1239-43. PubMed ID: 6761971 [No Abstract] [Full Text] [Related]
25. The effect of a topical antioxidant formulation including N-acetyl carnosine on canine cataract: a preliminary study. Williams DL; Munday P Vet Ophthalmol; 2006; 9(5):311-6. PubMed ID: 16939459 [TBL] [Abstract][Full Text] [Related]
26. Treatment of cataracts - vision for the future. Biswas S; Harris F; Phoenix DA Biologist (London); 2001 Dec; 48(6):273-7. PubMed ID: 11740079 [TBL] [Abstract][Full Text] [Related]
27. Why are physicians not persuaded by scientific evidence? A grounded theory interview study. Sekimoto M; Imanaka Y; Kitano N; Ishizaki T; Takahashi O BMC Health Serv Res; 2006 Jul; 6():92. PubMed ID: 16872522 [TBL] [Abstract][Full Text] [Related]
29. [On medicine therapy for cataracts (author's transl)]. Uchiyama U Nippon Ganka Gakkai Zasshi; 1974 Jan; 78(1):41-6. PubMed ID: 4856921 [No Abstract] [Full Text] [Related]
30. Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery. Stewart R; Grosserode R; Cheetham JK; Rosenthal A Clin Ther; 1999 Apr; 21(4):723-32. PubMed ID: 10363737 [TBL] [Abstract][Full Text] [Related]
31. [Use of Diacarb to attain hypotension in preoperative treatment of patients with different cataract etiology]. Alekseev BN; Iurova OV Vestn Oftalmol; 1997; 113(5):8-10. PubMed ID: 9508754 [TBL] [Abstract][Full Text] [Related]
32. Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial. Abelson MB; Heller W; Shapiro AM; Si E; Hsu P; Bowman LM; Am J Ophthalmol; 2008 Jun; 145(6):959-65. PubMed ID: 18374301 [TBL] [Abstract][Full Text] [Related]
33. [Effect of methyluracil (methacil) on the course of senile cataract]. Larionov LN Vestn Oftalmol; 1972; 5():84-6. PubMed ID: 4667905 [No Abstract] [Full Text] [Related]
34. Freeze-dried liposomes as potential carriers for ocular administration of cytochrome c against selenite cataract formation. Zhang J; Guan P; Wang T; Chang D; Jiang T; Wang S J Pharm Pharmacol; 2009 Sep; 61(9):1171-8. PubMed ID: 19703366 [TBL] [Abstract][Full Text] [Related]
35. [Biochemical aspects in the pathogenesis of senile cataract]. Jeru I; Boiştean V; Lupaşco V Oftalmologia; 1997; 41(3):207-8. PubMed ID: 9409962 [TBL] [Abstract][Full Text] [Related]
36. Ketorolac treatment of pseudophakic cystoid macular edema identified more than 24 months after cataract extraction. Weisz JM; Bressler NM; Bressler SB; Schachat AP Ophthalmology; 1999 Sep; 106(9):1656-9. PubMed ID: 10485530 [TBL] [Abstract][Full Text] [Related]
37. [Cataract surgery and eye drops--is a drop only a habit?]. Oskala P; Carlson P Duodecim; 2002; 118(15):1565-9. PubMed ID: 12244631 [No Abstract] [Full Text] [Related]
38. [Is there a drug treatment for cataract?]. Hockwin O Fortschr Med; 1982 Aug; 100(29):1355-9. PubMed ID: 7129292 [TBL] [Abstract][Full Text] [Related]
39. [Postoperative uveitis in cataract surgery]. Pop R; Nicula C Oftalmologia; 1997; 41(2):87-9. PubMed ID: 15328652 [TBL] [Abstract][Full Text] [Related]
40. Absorption of brimonidine 0.1% and 0.15% ophthalmic solutions in the aqueous humor of cataract patients. Cantor LB; WuDunn D; Catoira-Boyle Y; Yung CW J Glaucoma; 2008; 17(7):529-34. PubMed ID: 18854728 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]